National Cancer Institute; Notice of Closed Meetings, 66366 [E9-29814]

Download as PDF 66366 Federal Register / Vol. 74, No. 239 / Tuesday, December 15, 2009 / Notices Place: National Library of Medicine Building 38, 2nd Floor, Board Room, 8600 Rockville Pike, Bethesda, MD 20892. Contact Person: Karen Steely Program Assistant, Lister Hill National Center For Biomedical Communications National Library of Medicine Building 38A, Room 7S709, Bethesda, MD 20892. 301–435–3137. ksteely@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. (Catalogue of Federal Domestic Assistance Program Nos. 93.879, Medical Library Assistance, National Institutes of Health, HHS) Dated: December 8, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–29679 Filed 12–14–09; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health sroberts on DSKD5P82C1PROD with NOTICES National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, Nanosensing Platforms for Cancer Detection. Date: January 26, 2010. Time: 8 a.m. to 3 p.m. VerDate Nov<24>2008 17:23 Dec 14, 2009 Jkt 220001 Agenda: To review and evaluate contract proposals. Place: Bethesda North Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Irina Gordienko, PhD, Scientific Review Officer, Scientific Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm. 7073, Bethesda, MD 20892, 301–594–1566, gordienkoiv@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Nanoimaging Agents for Cancer Detection. Date: January 26–27, 2010 Time: 3 p.m. to 10 p.m. Agenda: To review and evaluate contract proposals. Place: Bethesda North Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Irina Gordienko, PhD, Scientific Review Officer, Scientific Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm. 7073, Bethesda, MD 20892, 301–594–1566, gordienkoiv@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Nanotherapeutics in Cancer Research. Date: January 27–28, 2010. Time: 10:30 a.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: Bethesda North Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Irina Gordienko, PhD, Scientific Review Officer, Scientific Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm. 7073, Bethesda, MD 20892, 301–594–1566, gordienkoiv@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, Collaborative Research in Integrative Cancer Biology and the TMEN. Date: March 3, 2010. Time: 8 a.m. to 7 p.m. Agenda: To review and evaluate grant applications. Place: The Legacy Hotel & Meeting Centre, 1775 Rockville Pike, Rockville, MD 20852. Contact Person: Savvas C Makrides, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm. 8050A, Bethesda, MD 20892, 301–496–7421, makridessc@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, NCI Cancer Prevention Research. Date: March 18–19, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance M Street Hotel, 1143 New Hampshire Avenue, NW., Washington, DC 20037. PO 00000 Frm 00095 Fmt 4703 Sfmt 4703 Contact Person: Irina Gordienko, PhD, Scientific Review Officer, Scientific Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm. 7073, Bethesda, MD 20892, 301–594–1566, gordienkoiv@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: December 7, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–29814 Filed 12–14–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the President’s Cancer Panel. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: President’s Cancer Panel. Date: February 2, 2010. Time: 8 a.m. to 4 p.m. Agenda: America’s Demographic and Cultural Transformation: Implications for the Cancer Enterprise. Place: Marriott Miami Biscayne Bay, 1633 North Bayshore Drive, Miami, FL 33132. Contact Person: Abby B. Sandler, PhD, Executive Secretary, Chief, Institute Review Office, Office of the Director, 6116 Executive Blvd., Suite 220, MSC 8349, National Cancer Institute, NIH, Bethesda, MD 20892–8349, (301) 451–9399, sandlera@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: deainfo.nci.nih.gov/advisory/pcp/pcp.htm, where an agenda and any additional E:\FR\FM\15DEN1.SGM 15DEN1

Agencies

[Federal Register Volume 74, Number 239 (Tuesday, December 15, 2009)]
[Notices]
[Page 66366]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-29814]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Nanosensing Platforms for Cancer Detection.
    Date: January 26, 2010.
    Time: 8 a.m. to 3 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda North Marriott Hotel & Conference Center, 
Montgomery County Conference Center Facility, 5701 Marinelli Road, 
North Bethesda, MD 20852.
    Contact Person: Irina Gordienko, PhD, Scientific Review Officer, 
Scientific Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., 
Rm. 7073, Bethesda, MD 20892, 301-594-1566, 
gordienkoiv@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Nanoimaging Agents for Cancer Detection.
    Date: January 26-27, 2010
    Time: 3 p.m. to 10 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda North Marriott Hotel & Conference Center, 
Montgomery County Conference Center Facility, 5701 Marinelli Road, 
North Bethesda, MD 20852.
    Contact Person: Irina Gordienko, PhD, Scientific Review Officer, 
Scientific Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., 
Rm. 7073, Bethesda, MD 20892, 301-594-1566, 
gordienkoiv@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Nanotherapeutics in Cancer Research.
    Date: January 27-28, 2010.
    Time: 10:30 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Bethesda North Marriott Hotel & Conference Center, 
Montgomery County Conference Center Facility, 5701 Marinelli Road, 
North Bethesda, MD 20852.
    Contact Person: Irina Gordienko, PhD, Scientific Review Officer, 
Scientific Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., 
Rm. 7073, Bethesda, MD 20892, 301-594-1566, 
gordienkoiv@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Collaborative Research in Integrative Cancer Biology and the 
TMEN.
    Date: March 3, 2010.
    Time: 8 a.m. to 7 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Legacy Hotel & Meeting Centre, 1775 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Savvas C Makrides, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., 
Rm. 8050A, Bethesda, MD 20892, 301-496-7421, 
makridessc@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, NCI Cancer Prevention Research.
    Date: March 18-19, 2010.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Renaissance M Street Hotel, 1143 New Hampshire Avenue, 
NW., Washington, DC 20037.
    Contact Person: Irina Gordienko, PhD, Scientific Review Officer, 
Scientific Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., 
Rm. 7073, Bethesda, MD 20892, 301-594-1566, 
gordienkoiv@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: December 7, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-29814 Filed 12-14-09; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.